Deep Track Capital, LP - Feb 18, 2025 Form SCHEDULE 13D/A Schedule Report for Dynavax Technologies Corporation (DVAX)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Biotechnology Master Fund, Ltd.
Symbol
DVAX
Shares outstanding
132M shares
Disclosed Ownership
17.8M shares
Ownership
13.5%
Form type
SCHEDULE 13D/A
Date filed
2/19/2025, 09:51 PM
Date of event
Feb 18, 2025

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Biotechnology Master Fund, Ltd. 13.5% 17.8M 0 17.8M /s/ David Kroin David Kroin, Director 0002015536
Deep Track Capital, LP 13.5% 17.8M 0 17.8M /s/ David Kroin David Kroin, Managing Member of the General Partner of Deep Track Capital, LP 0001856083
David Kroin 13.5% 17.8M 0 17.8M /s/ David Kroin David Kroin 0001397513